Cagrilintide 5mg Peptides
Advance metabolic pathway research with a precisely manufactured amylin analog you can trust.
This Cagrilintide 5mg lyophilized research peptide vial from Peptide Scientific Labs is prepared for controlled laboratory workflows. Supplied as a lyophilized powder (vial format), it features the amylin analog Cagrilintide as the active ingredient with a total strength of 5mg, enabling consistent setup across assay designs and method development.
- Each vial contains 5mg of Cagrilintide, an amylin receptor agonist widely investigated in models of satiety signaling, energy balance, gastric motility pathways, and amylin receptor pharmacology for mechanistic and translational research.
Non-edible and intended strictly for laboratory use, this vial is designed for researchers who require dependable handling characteristics and batch-to-batch consistency. Typical applications may include receptor-binding assays, signaling pathway mapping, dose-ranging method development, stability and compatibility studies, and exploratory combination models within metabolic research frameworks. The lyophilized format supports careful reconstitution under institutional SOPs, facilitating accurate aliquoting and repeatable experimentation.
Peptide Scientific Labs prioritizes analytical rigor and supply integrity. Each lot is evaluated for purity by HPLC and identity confirmation by mass spectrometry, with traceable lot coding and a lot-specific certificate of analysis for documentation. Vials are prepared in controlled environments with careful material handling to support low bioburden expectations for research settings. Our USA-based production and quality systems emphasize reliability, transparency, and disciplined process control from synthesis through final packaging.
Choose Cagrilintide from a brand built around standards: clearly labeled content, consistent specifications, and professional presentation to streamline laboratory adoption. Our focus is to provide a dependable research input so that your data reflect the science, not variability in starting materials.
Research Use Only: Not a drug, food, or cosmetic. Not for human or veterinary use. Handle using appropriate PPE and established laboratory safety practices. Reconstitute, store, and dispose of materials according to your institution’s protocols and applicable regulations.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Cagrilintide?
Cagrilintide is a long-acting amylin analog used in metabolic research. It belongs to the incretin-adjacent appetite-regulation space rather than the classic growth-hormone or repair-peptide category. On a product page, the accurate framing is that it is a research compound studied for metabolic signaling, not an approved consumer-use peptide.
What is Cagrilintide typically studied for?
Cagrilintide is usually studied in relation to appetite regulation, satiety signaling, gastric-emptying effects, and body-weight change in experimental models. It is also often discussed alongside GLP-1-based research because both areas intersect around energy intake and metabolic control.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
